Accelmed Partners raises USD400m to invest in commercial stage healthtech
Accelmed Partners (Accelmed), a private equity firm focused on acquiring and investing in US commercial stage, lower middle market HealthTech companies, has closed its oversubscribed second fund, Accelmed Fund II (Fund II) at the fund’s hard cap of USD400 million, exceeding its original USD300 million target. Fund II received significant